| |
|
|
|
Avadel Pharmaceuticals plc  
|
|
2.73 -0.46 (-0.14%) |
06-17 16:00 |
|
Open: |
3.06 |
Pre close: |
3.19 |
Target:
|
4.18
|
|
High: |
3.2 |
Low: |
2.72 |
Resistance:
|
3.58
4.18
|
|
Volume: |
739,626 |
Market Cap: |
102M |
Support:
|
2.07
 1.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.88
|
MACD |
MACD(12,26):
|
0.40  |
|
MA(20): |
2.02 |
Signal(12,26,9): |
0.29 |
|
MA(100): |
1.79 |
Stochastic Oscillator |
%K(14,3):
|
71.44 |
|
MA(250): |
3.34 |
%D(3): |
80.29 |
|
Average Volume(K) |
3-Month: |
32325
|
52-Week |
High:
|
7.57 |
|
10-Days: |
69007 |
Low: |
1.03 |
|
RSI |
RSI(14):
|
63.73 |
Change(%): |
-63.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.000 |
Return on Equity (ttm) |
-275.7 |
Shares Out. (M) |
37.36 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-38.9 |
Shares Float (M) |
36.07 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.15 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-50.6 |
% Held by Institutions |
62.70 |
|
Forward EPS |
-0.060 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
16.800 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.37 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.16 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-85.91 |
P/S |
43773732.00 |
|
Operating Margin |
-64.64 |
Levered Free Cash Flow
(M) |
-90.76 |
P/CF |
-1.19 |
|
|
|
|
|
|
